| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
112,320,000 |
| Market
Cap: |
48.31(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.4301 - $0.4301 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Avalo Therapeutics is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology and rare genetic diseases. Co.'s clinical-stage pipeline include: AVTX-002, which is developing for the treatment of non-eosinophilic asthma, inflammatory bowel disease; AVTX-007, which is developing AVTX-007 for the treatment of Still's Disease; AVTX-801, which is a D-galactose substrate replacement therapy for the treatment of phosphoglucomutase 1 deficiency; and AVTX-803, which is a L-fucose substrate replacement therapy for the treatment of LADII.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
79,351 |
662,763 |
| Total Buy Value |
$0 |
$0 |
$272,578 |
$643,635 |
| Total People Bought |
0 |
0 |
3 |
4 |
| Total Buy Transactions |
0 |
0 |
18 |
32 |
| Total Shares Sold |
0 |
0 |
5,291,542 |
5,291,542 |
| Total Sell Value |
$0 |
$0 |
$3,199,077 |
$3,199,077 |
| Total People Sold |
0 |
0 |
2 |
2 |
| Total Sell Transactions |
0 |
0 |
4 |
4 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Boyd Steven |
Director |
– • • |
2019-05-14 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
18,324,285 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-05-14 |
4 |
B |
$5.27 |
$25,870 |
D/D |
4,909 |
18,324,285 |
3.92 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-05-13 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
18,319,376 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-05-13 |
4 |
B |
$4.85 |
$61,047 |
D/D |
12,587 |
18,319,376 |
3.92 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-05-10 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
18,306,789 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-05-10 |
4 |
B |
$4.95 |
$12,395 |
D/D |
2,504 |
18,306,789 |
3.92 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-03-27 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
18,304,285 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-03-27 |
4 |
B |
$5.48 |
$54,800 |
D/D |
10,000 |
18,304,285 |
3.92 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-03-26 |
4 |
B |
$0.00 |
$55,200 |
I/I |
10,000 |
290,000 |
2.25 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-03-26 |
4 |
B |
$5.48 |
$88,984 |
D/D |
16,238 |
18,294,285 |
3.92 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-03-25 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
18,278,047 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-03-25 |
4 |
B |
$5.40 |
$74,315 |
D/D |
13,762 |
18,278,047 |
3.92 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-03-08 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
18,264,285 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-03-08 |
4 |
B |
$5.46 |
$21,835 |
D/D |
4,000 |
18,264,285 |
3.92 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-03-07 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
18,260,285 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-03-07 |
4 |
B |
$5.36 |
$32,807 |
D/D |
6,000 |
18,260,285 |
3.92 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-03-06 |
4 |
B |
$0.00 |
$1,314,500 |
I/I |
239,000 |
18,254,285 |
2.25 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-03-06 |
4 |
B |
$5.50 |
$690,172 |
D/D |
125,486 |
18,254,285 |
3.92 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-01-11 |
4 |
B |
$3.88 |
$49,313 |
I/I |
12,651 |
18,169,799 |
2.25 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-01-10 |
4 |
B |
$3.70 |
$2,958 |
I/I |
800 |
18,157,148 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-01-09 |
4 |
B |
$3.79 |
$2,064 |
I/I |
545 |
18,156,348 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-01-08 |
4 |
B |
$3.70 |
$1,849 |
I/I |
500 |
18,155,803 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-01-07 |
4 |
B |
$3.65 |
$23,745 |
I/I |
6,504 |
18,155,303 |
2.17 |
- |
|
| Boyd Steven |
Director |
– • • |
2019-01-04 |
4 |
B |
$3.42 |
$68,320 |
I/I |
20,000 |
18,148,799 |
2.25 |
- |
|
| Boyd Steven |
Director |
– • • |
2018-12-31 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
18,128,799 |
2.17 |
- |
|
440 Records found
|
|
Page 8 of 18 |
|
|
